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Abstract 
    The aim of the present study was to determine the effects of conjugated linoleic acid (CLA) and 
tetradecylthioacetic acid (TTA) on growth performance, and lipid and fatty acid metabolism in Atlantic 
cod. The overall objective being to test the hypotheses that CLA and TTA have beneficial effects in 
cod culture including decreased liver size and proportion through decreased lipid content, and increased 
nutritional quality through effects on fatty acid compositions including accumulation of bioactive fatty 
acids, CLA and TTA, in flesh.  Juvenile cod were fed for three months on fish meal and fish oil diets of 
basically commercial formulation, but containing either 0.5% or 1% CLA, or 0.5% TTA.   The effects 
of the functional fatty acids on growth, feed efficiency, body proximate composition, liver weight and 
lipid composition, fatty acid compositions of flesh and liver, and key enzymes of fatty acid oxidation 
were determined. Dietary CLA and TTA had no effect on growth parameters in cod juveniles, but 
viscero- and hepato-somatic indices were increased in fish fed 0.5% CLA and TTA, respectively. 
Proximate composition of whole fish was not affected by CLA or TTA, and there were no major effects 
of either functional fatty acid on lipid contents and compositions of liver and flesh. Dietary CLA and 
TTA were both incorporated into tissue lipids, with CLA deposited to a greater extent in liver, whereas 
TTA was deposited to a greater extent in flesh.  In liver, acyl CoA oxidase (ACO) activity, but not 
carnitine palmitoyltransferase-I (CPT-I), was increased by CLA, whereas dietary TTA increased both 
ACO and CPT-I activities.   In contrast, ACO activity was reduced by both CLA and TTA in red and 
white muscle, whereas CPT-I activity was generally not affected by CLA and TTA in either muscle 
tissue. Therefore, the results only partially supported the hypotheses tested, as CLA and TTA had few 
beneficial effects in Atlantic cod and did not enhance growth parameters, or improve feed conversion 
or potential yield through decreased adiposity or liver lipid deposition.  However, nutritional quality 
could be enhanced, and cod fed CLA and/or TTA could be beneficial in the human diet, through 
provision of bioactive fatty acids with no detrimental effects on n-3 PUFA levels.  
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1. Introduction 
 
    Aquaculture is the fastest growing animal-based agricultural food production sector, expanding at 
more than 9% per year, and currently contributes over one third of all the fish in the human food basket 
(Tacon, 2003).   Farming of finfish in seawater is dominated by Atlantic salmon (Salmo salar L.), but 
other marine species are becoming increasingly important, including warmer water species such as 
gilthead sea bream (Sparus aurata), European sea bass (Dicentrarchus labrax) and turbot (Psetta 
maximus) and, in colder waters, halibut (Hippoglossus hippoglossus).  Recently, declining catches and 
high market prices have seen Atlantic cod (Gadus morhua L.) emerge as the most promising species 
for culture in the northern Atlantic area (Brown and Puvanendran, 2002; Brown et al., 2003) with 
production expanding in Norway and Scotland.  A major factor influencing the commercial success of 
cod culture will be the development of diets and feeding strategies to maximise growth and feed 
conversion efficiencies (Morais et al., 2001; Lall and Nanton 2002; Hemre et al., 2003, 2004; 
Rosenlund et al., 2004).  One major issue pertaining to this is that cod store lipid in the liver and, in 
early studies, farmed fish were reported to have enlarged livers and display a hepato-somatic index 
(HSI) of over 12% compared to values of 2-6% in wild fish (Jobling, 1988).  In early feeding trials with 
captive cod, the HSI increased from 9.5% to an average of 13%, and liver fat increased from around 
55% to 67-70% in cod fed various dietary oils (Lie et al., 1986). Further studies have consistently 
shown that farmed cod have high liver lipid levels that can exceed 70% of wet weight, and have higher 
HSI and condition factor (K) than their wild counterparts (Dos Santos et al., 1993; Shahidi and 
Dunajski, 1994; Grant et al., 1998; Gildberg, 2004).   Dietary formulations in aquaculture have tended 
to exhibit an upward trend in dietary lipid as this has successfully increased weight gains, but several 
studies have shown that a potential detrimental side-effect of high fat diets is the deposition of excess 
lipid in tissues (Sargent et al., 2002; Tocher, 2003).  This may exacerbate the enlarged fatty liver 
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problem in farmed cod and so it is important to gain a clearer understanding of the mechanisms 
determining lipid and fatty acid homeostasis and deposition. 
        Conjugated linoleic acid (CLA) describes a group of geometric and positional conjugated isomers 
of linoleic acid (18:2n-6) that are found in dairy products and meat, with the two main naturally 
occurring isomers being cis-9,trans-11 and trans-10,cis-12 (Pariza et al., 2001).  There is increasing 
evidence that dietary CLA decreases body fat and increases lean body mass (Thiel-Cooper et al., 2001; 
Tischendorf et al., 2002; Yamasaki et al., 2003), and thus attenuates obesity in several animal models 
(Delany and West, 2000; Wang and Jones, 2004). Proposed anti-obesity mechanisms of CLA include 
decreased energy/food intake and increased energy expenditure (Ohnuki et al., 2001; Terpstra et al., 
2002), decreased preadipocyte differentiation and proliferation (Evans et al., 2000), decreased 
lipogenesis (Brown et al., 2001; Oku et al., 2003), and increased lipolysis and fatty acid oxidation 
(Evans et al., 2002). Thus, dietary CLA could be beneficial to cod culture if these effects on body 
composition and lipid metabolism could be reproduced in farmed fish. 
     Other bioactive fatty acids include the sulfur-substituted analogs such as the 3-thia fatty acid 
tetradecylthioacetic acid [CH3-(CH2)13-S-CH2-CO2H; TTA] (Berge et al., 1989).   TTA cannot be β-
oxidized due to the position of the sulfur in the carbon chain and thus it is metabolized in mammals via 
ω-hydroxylation in the endoplasmic reticulum followed by peroxisomal oxidation from the ω-end 
producing short chain sulfoxy dicarboxylic acids (Skrede et al., 1997). In mammals, TTA increases 
both liver and muscle mitochondrial and peroxisomal fatty acid oxidation, decreases plasma lipids and 
adipose tissue mass, and increases free fatty acid transport from peripheral tissues to liver (Berge et al., 
2002). Therefore, TTA is another fatty acid analog that could have effects on lipid and fatty acid 
metabolism in Atlantic cod that may be beneficial in a farming context.  
          The aims of the present study were to determine the effects of CLA and TTA on growth 
performance, lipid content, composition and metabolism in Atlantic cod. The overall objective being to 
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test the hypotheses that CLA and TTA have beneficial effects in cod culture including decreased liver 
size and proportion through decreased lipid content, and increased nutritional quality through effects on 
fatty acid compositions including accumulation of bioactive fatty acids, CLA and TTA, in flesh.  
Juvenile cod were fed for three months on fish meal and fish oil diets of basically commercial 
formulation, but containing either 0.5% or 1% CLA, or 0.5% TTA.   The effects of the functional fatty 
acids on growth, feed efficiency, body proximate composition, liver weight and lipid composition, fatty 
acid compositions of flesh and liver, and key enzymes of fatty acid oxidation were determined.   
 
2. Materials and methods 
 
2.1. Diets and Animals 
   The dietary trial was performed at Viking Fish Farms, Ardtoe Marine Laboratory, Ardnamurchan, 
Scotland, between October 2005 and January 2006.  Hatchery reared Atlantic cod of the 2004 year 
class were randomly distributed between twelve indoor, round tanks of 1.5m3 volume (1.72m 
diameter). The initial stocking density was 50 fish of average fish weight 127 ± 15g per tank (5.8 
kg/m3), with 25 fish per tank individually PIT tagged (Passive Induced Transponder, Fish Eagle, 
Gloucestershire, England) prior to stocking.  Water temperature was maintained at 12 oC (±1 oC) 
throughout the trial, with a light regime of 12L:12D.  Four experimental diets were fed to triplicate 
tanks for three months, with feed supplied to appetite manually in one morning feed over a period of 
one hour. Waste feed pellets were collected and counted one hour later. The experimental diets were 
formulated to satisfy the nutritional requirements of marine fish (National Research Council 1993), and 
were formulated and manufactured by BioMar A/S, Brande, Denmark (Table 1).  Isonitrogenous diets 
were based on fish meal and standard Northern hemisphere fish oil with CLA and TTA replacing some 
of the fish oil to produced diets containing 0, 0.5 and 1% CLA, and 0.5% TTA (as percentage of total 
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diet). Diets were identical in formulation other than fatty acid composition with CLA (LUTA-CLATM 
60, containing 60% CLA methyl esters as a 50:50 mixture of c9, t11 and t10, c12 isomers; BASF AG, 
Ludwigshafen, Germany) and TTA (supplied by Dr Rolf Berge, Thia Medica A.S., Bergen, Norway) 
balanced by fish oil (capelin oil, Norsemeal Ltd., London, UK). The fatty acid compositions of the 
diets are presented in Table 2. 
 
2.2. Sampling protocols  
 
   At the initiation and termination of the trial, all the fish in each tank were anaesthetized with 
Metomidate (50 mg/L), identified by PIT tag if present, and individually weighed and fork length 
recorded.  At the end of the trial, 9 fish per tank (27 per dietary treatment) were killed by percussion 
stunning then sampled for compositional analyses, with 3 whole fish/tank frozen immediately at -20 oC 
for whole body compositional (proximate) analyses. The remaining sample fish were eviscerated and 
used for biometric determinations (hepato-, and viscero-somatic indices) and for tissue lipid analyses.  
White (fast) and red (slow) muscle samples were excised from the epaxial myotomes anterior to the 
first dorsal fin ray (Flesh Quality Cut) and livers were taken from six fish, pooled in two samples of 3 
fish each, and frozen immediately in liquid nitrogen (livers) or dry ice (flesh).  All samples were 
subsequently stored at –80 oC prior to analyses.   
 
2.3. Proximate analyses 
 
   Moisture content of whole fish was determined after drying in an oven at 80 0C for a minimum of 72 
h.  The dried fish samples were then rigorously blended into a homogeneous crumble/meal and used for 
determination of whole body lipid, protein and ash contents.  Lipid content in 1 g samples of dried fish 
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crumb was determined using the Soxhlet method with extraction in petroleum ether at 120 oC (Avanti 
Soxtec 2050 Auto Extraction apparatus; Foss, Warrington, UK).  Protein content (N x 6.25) was 
determined in the fish crumble using the automated Kjeldahl method (Tecator Kjeltec Auto 1030 
Analyser; Foss, Warrington, UK). Ash contents were determined after heating portions of the fish 
crumble at 160 oC for 48 h. 
 
2.4. Lipid analyses  
 
     Liver and skinned and deboned flesh samples, each consisting of three fish, were homogenized into 
pooled “pates”. Total lipid was extracted from diets or 1g portions of tissue pates by homogenizing in 
20 volumes of chloroform/methanol (2:1, v/v) in an Ultra-Turrax tissue disrupter (Fisher Scientific, 
Loughborough, U.K.). Total lipid was prepared according to the method of Folch et al. (1957) and lipid 
content determined gravimetrically as described previously (Kennedy et al., 2005).  Tissue lipid class 
compositions were determined by single-dimension double-development high-performance thin-layer 
chromatography (HPTLC) and densitometry using a Camag 3 TLC Scanner (Camag, Muttenz, 
Switzerland) and winCATS software as described in Kennedy et al. (2005). Fatty acid methyl esters 
(FAME) from diets and tissue total lipid were prepared by acid-catalyzed transesterification of total 
lipid similar to the method of Christie (1982) except that the reaction was performed at 80 oC for 3 h. 
Extraction and purification of FAME was performed as described by Tocher and Harvie (1988). FAME 
were separated and quantified by gas-liquid chromatography (Carlo Erba Vega 8160, Milan, Italy) 
using a 30m x 0.32 mm i.d. capillary column (CP Wax 52CB, Chrompak, London, U.K.) and on-
column injection. Hydrogen was used as carrier gas and temperature programming was from 50oC to 
150oC at 40oC min-1 and then to 230oC at 2.0oC min-1.  Methyl esters were identified and quantified as 
described previously (Kennedy et al., 2005). 
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 2.5. Assay of carnitine palmitoyl acyltransferase I (CPT-I) and  acylCoA oxidase (ACO) 
 
   Liver, red and white muscle were weighed, diced and homogenized to 20% (w/v) in 0.25 M sucrose 
in 10 mM N-2-hydroxyethylpiperazine-N´-2-ethanesulfonic acid (HEPES) buffer and 1 mM EDTA, pH 
7.4. The homogenates were centrifuged at 1880 x g for 10 min at 4˚C, the floating fat layer aspirated 
and the post-nuclear fractions collected, 100 µl taken for protein determination according to Lowry et 
al. (1957) after incubation with 0.45 ml of 0.25% (w/v) SDS/1M NaOH for 45 min at 60oC, and 
portions used immediately for determination of enzyme activities. CPT-I activity was estimated by 
determining the production of palmitoyl[3H]carnitine from palmitoyl CoA and [3H]carnitine essentially 
as described by Saggerson and Carpenter (1986).  ACO activity was measured by a spectrophotometric 
assay based on the determination of hydrogen peroxide production coupled to the oxidation of leuco-
dichlorofluorescein (DCF) in a reaction catalysed by exogenous peroxidase (Small et al., 1985).  
2.6. Materials 
 
    [Methyl-3H] L-carnitine hydrochloride (60-86 Ci/mmol) was obtained from GE Healthcare Bio-
Sciences (Little Chalfont, Bucks, U.K.). Aminotriazole, BHT, carnitine, dichlorofluorescein diacetate, 
dimethylformamide, dithiothreitol, EDTA, FAF-BSA, horseradish peroxidase, leuco-DCF, N-
acetylcysteine, NADP, palmitoyl-CoA and triton X-100 were obtained from Sigma Chemical Co. 
(Poole, U.K.). TLC (20 cm x 20 cm x 0.25 mm) and HPTLC (10 cm x 10 cm x 0.15 mm) plates, 
precoated with silica gel 60 (without fluorescent indicator) were obtained from Merck (Darmstadt, 
Germany).  All solvents were HPLC grade and were obtained from Fisher Scientific UK, 
Loughborough, England. 
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2.7. Statistical analysis 
 
         All data are presented as means ± SD (n value as stated). Percentage data and data which were 
identified as non-homogeneous (Bartlett’s test) were subjected to arcsine transformation before 
analysis.  The effects of dietary CLA and TTA were determined by one-way analysis of variance 
(ANOVA) with Tukey’s post-tests to determine significance of differences due to functional fatty 
acids. Differences were regarded as significant when P < 0.05 (Zar, 1984). 
 
3. Results  
 
3.1. Diet compositions 
 
   The control fish oil diet contained 41% total polyunsaturated fatty acids (PUFA), including 14% 
eicosapentaenoic acid (20:5n-3; EPA), 13% docosahexaenoic acid (22:6n-3; DHA) and almost 6% 
18:2n-6, 32% total saturates, mainly 16:0, and 27% total monoenes, mainly 18:1n-9 and 16:1n-7 (Table 
2).  Inclusion of CLA in the diets resulted in levels of total CLA of 3.5% and 6.3% of total fatty acids 
at the 0.5 and 1% inclusion levels, respectively.  CLA inclusion resulted in lower levels of 14:0, 16:0, 
EPA and DHA, but 18:1n-9 and 18:2n-6 (the other main components of the CLA mixture) increased 
(Table 2).  Inclusion of 0.5% TTA resulted in TTA at a level of 2.8% of total fatty acids in the diet, and 
lower levels of 14:0 and 18:0.  
 
3.2. Growth, biometry and whole body proximate compositions 
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Growth of the cod was unaffected by either CLA or TTA with neither having any significant effect on 
final weight, SGR or thermal growth coefficient (TGC) (Table 3). Viscero-somatic index (VSI) was 
lower in fish fed 0.5% CLA, and HSI was lower in fish fed TTA with condition factor slightly lower in 
fish fed these diets compared to fish fed fish oil.  There were slight effects on feed efficiency (FCR) 
and gutted weight that were unlikely to be commercially important. Neither dietary CLA nor TTA had 
any effect on the proximate compositions of whole fish (Table 4).  
 
3.3. Lipid contents and class compositions of liver and flesh 
 
     The lipid content of the livers, which varied between 50 and 55% of the wet weight, was not 
strongly affected by dietary CLA or TTA (Table 5). Neutral lipids accounted for around 97% of liver 
total lipid with triacylglycerol (TAG) accounting for between 91 and 93%, and these components were 
slightly lower in fish fed the diet containing 1% CLA.  TTA had no significant effect on liver neutral 
lipid or TAG levels.  Dietary CLA and TTA had no effect on flesh lipid contents, which were constant 
at 0.8% of wet weight (Table 5).  Polar lipids, mainly phosphatidylcholine (PC) and 
phosphatidylethanolamine (PE), predominated in flesh accounting for 57 to 61% of total lipid, with 
neutral lipids, mainly cholesterol and free fatty acid (FFA), accounting for 39 to 43%.  FFA and steryl 
esters were highest in fish fed 0.5% CLA, whereas flesh TAG was slightly, but significantly, higher in 
fish fed TTA (Table 5). 
 
3.4. Fatty acid compositions of liver and flesh 
 
    Dietary CLA and TTA were both incorporated into tissue lipids, but it was noteworthy that CLA was 
deposited to a greater extent in liver lipids (Table 6), whereas TTA was deposited to a greater extent in 
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flesh (Table 7). Thus, CLA accounted for 1.5 and 2.9% of total fatty acids in livers of fish fed 0.5 and 
1% CLA, respectively, whereas TTA accounted for 0.6% of liver fatty acids in fish fed 0.5% TTA 
(Table 6).  In contrast, TTA accounted for 1.6% of flesh fatty acids in TTA-fed fish, compared to 0.8 
and 1.9% CLA in fish fed the lower and higher CLA, respectively (Table 7).  Dietary CLA had no 
significant effect on the proportions n-3 or n-6 PUFA in either liver or flesh, but in fish fed TTA there 
were decreased percentages of monoenes, n-6 PUFA and EPA, but an increased proportion of DHA in 
the flesh (Tables 6 and 7).  Dietary CLA resulted in increased percentages of 18:0 and decreased 
percentages of 18:1n-9 and total monoenes in both tissues, but especially liver. 
 
3.5. Carnitine palmitoyltransferase I (CPT-I) and acylCoA oxidase (ACO) activities in liver, red and 
white muscle  
 
   There was a trend for CPT-I activity in liver to be increased by dietary CLA and TTA, although it 
was only significant in the case of TTA (Fig.1).  In red muscle, a dietary level of 1% CLA resulted in 
increased CPT-1 activity, but 0.5% dietary CLA or TTA had no effect.  In contrast, CPT-1 activity in 
white muscle was not affected by any dietary treatment.  ACO activity in liver was significantly 
increased by both dietary CLA and TTA (Fig.2).  Conversely, ACO activity in both red and white 
muscle was decreased by CLA and TTA, with the effects being significant for CLA in red muscle and 
TTA in white muscle.  
 
4. Discussion 
 
    Feeding CLA reduced liver TAG levels in rats (Rahman et al., 2002), and so the primary hypothesis 
we aimed to test in the present trial was that dietary CLA or TTA could have beneficial effects on lipid 
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metabolism in Atlantic cod, specifically that they could lower liver lipid levels, and liver size.  The 
results show clearly that the hypothesis was not proved and that neither of these bioactive fatty acids 
had a major effect on liver lipid content or relative liver size as determined by HSI in cod.  TTA did 
induce a statistically significant decrease in HSI compared to control fish fed FO alone or fish fed 
CLA, but the index was still over 10%, and there was no difference in liver lipid content.   In contrast, 
TTA fed to Atlantic salmon smolts at 0.6% of the diet resulted in a slight, but significant, increase in 
HSI and higher liver lipid content, although the latter was not significant (Moya-Falcon et al., 2004). In 
the present trial, CLA at 0.5% inclusion resulted in a higher HSI in the cod, and increased HSI in 
response to feeding CLA had been previously reported in hybrid striped bass (Morone saxatilis x M. 
chrysops) (Twibell et al., 2000), yellow perch (Perca flavescens) (Twibell et al., 2001) and tilapia 
(Oreochromis niloticus) (Yasmin et al., 2004).  Perhaps surprisingly, liver lipid content was reduced by 
CLA in striped bass and yellow perch despite the increased HSI (Twibell et al., 2000, 2001). In 
Atlantic salmon smolts there were trends of increasing HSI and liver lipid in fish fed CLA at 1 and 2% 
of the diet, although the data were not statistically significant (Kennedy et al., 2005).  In contrast, CLA 
at up to 1% had no effect on HSI or liver lipid content in juvenile channel catfish (Ictalurus punctatus) 
(Twibell et al., 2003), and HSI was unaffected by dietary CLA at up to 2% in rainbow trout juveniles 
(Figueirdo-Silva et al., 2005).  
       Dietary CLA can have beneficial effects on body composition in mammals, with decreased body 
fat and increased lean body mass being reported in mice, rats and pigs (Wang and Jones, 2004).   
However, in the present trial with cod, neither CLA nor TTA had any effect on proximate composition 
of whole fish.   Whole body proximate composition was also unaffected by dietary CLA in salmon fry 
and smolts (Berge et al., 2004; Kennedy et al., 2005), and rainbow trout juveniles (Figueirdo-Silva et 
al., 2005). Similarly, dietary CLA had no effect on carcass lipid or intraperitoneal fat in catfish 
(Twibell and Wilson, 2003), or on tissue lipid contents in tilapia (Yasmin et al., 2004). Furthermore, 
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VSI was unaffected by dietary CLA up to 2% in both Atlantic salmon smolts (Kennedy et al., 2005) 
and rainbow trout (Figueirdo-Silva et al., 2005). However, intraperitoneal fat was decreased by dietary 
CLA in hybrid striped bass (Twibell et al., 2000) and, in the present trial, visceral fat may have been 
reduced in cod fed 0.5% CLA as VSI was lower in this group along with higher HSI, which may 
suggest some redistribution of fat. However, fat redistribution has not been apparent in other trials with 
fish. 
       Studies have suggested that CLA increased fatty acid oxidation in mouse liver  (Degrace et al., 
2004) and a variety of tissues in rats (Rahman et al., 2001) via an increase in CPT-I activity.  The 
present study showed that CPT-I activity in cod liver was not increased by dietary CLA, suggesting 
that mitochondrial β-oxidation would not be increased.  Measuring this parameter would require fresh 
tissue but, unfortunately, assays using radioactive isotopes were not possible at the commercial farm 
site. In contrast, ACO in liver was significantly increased by dietary CLA in cod, suggesting that 
dietary CLA may have a greater effect on peroxisomal rather than mitochondrial fatty acid oxidation in 
cod liver.  Interestingly, fatty acid β-oxidation activity was recently measured in a related gadoid, 
haddock Melanogrammus aeglefinus L., and it was shown that peroxisomal β-oxidation predominates 
over mitochondrial β-oxidation in liver (Nanton et al., 2003).  Similarly, fatty acid oxidation in Atlantic 
salmon liver is principally due to peroxisomal, rather than mitochondrial, β-oxidation (Frøyland et al., 
2000). In contrast, both CPT-I and ACO were significantly increased by dietary TTA in liver, which 
suggests that TTA could increase fatty acid oxidation in cod liver. Previously, TTA was shown to 
increase β-oxidation capacity in both homogenates and the mitochondrial fraction of liver in salmon 
(Vegusdal et al., 2005).  In contrast to liver, ACO activity was generally decreased by both CLA and 
TTA in the muscle tissues. Although this could indicate lower peroxisomal fatty acid oxidation, it is 
unlikely to have a physiologically significant effect as fatty acid oxidation activity in both red and 
white muscle of gadoids is predominantly mitochondrial rather than peroxisomal (Nanton et al., 2003).  
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However, it does not appear that dietary CLA or TTA have any significant effect on mitochondrial 
fatty acid oxidation in cod muscle tissues as, other than slightly increased CPT-I activity in red muscle 
of fish fed 1% CLA, CPT-I activity was not affected by dietary TTA or the lower level of CLA. In 
Atlantic salmon, fatty acid oxidation capacity was not affected by dietary CLA in either red or white 
muscle (Kennedy et al., 2006).  
     A further aim of the present trial was to determine if dietary CLA or TTA had beneficial effects on 
fatty acid compositions in Atlantic cod. This part of the study revealed a very interesting result with 
TTA accumulating in flesh to a greater extent than the equivalent dietary level of CLA and also to a 
greater extent than in liver.  In contrast, CLA was incorporated to a greater extent in liver lipids 
compared to flesh. TAG predominates in liver of cod whereas polar lipids predominate in flesh, and so 
these data suggest that TTA may be deposited to a greater extent in polar lipids (phospholipids) and 
CLA to a greater extent in TAG.  In Atlantic salmon fed TTA, flesh fatty acid compositions were not 
reported but, of the tissues investigated, the highest incorporation was found in gills with 
approximately equal percentages, 0.8% and 0.7% of total fatty acids in phospholipids and TAG, 
respectively, in fish fed TTA at 0.6% of total diet (Moya-Falcon et al., 2004). Furthermore, TTA in 
both heart and liver was only recovered in phospholipids and not TAG.  Thus it appears that bioactive 
fatty acids similar to, and including, TTA could be efficiently accumulated in ‘lean” fish such as cod 
with low flesh oil contents.  It remains to be established whether fatty acid analogues such as TTA are 
feasible or, indeed, appropriate as supplements for the human diet (Berge et al., 2002).  However, CLA 
may be better delivered to humans via oily fish with the level accumulating in salmon and trout fed 
CLA at 2% of diet reaching 7% in flesh (dietary lipid 16-17%), (Kennedy et al., 2005; Bandarra et al., 
2006), or 4% in flesh of salmon smolts (dietary lipid 34%) (Kennedy et al., 2005), and 7% in whole 
salmon fry fed 2% CLA (24% dietary lipid) (Berge et al., 2004).  Similarly, striped bass with high flesh 
lipid (>15%) accumulated CLA to over 7% of total fatty acids in fish fed CLA at 1% of diet, whereas 
the levels of CLA accumulated in yellow perch with only 3% lipid in the flesh were much lower 
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(Twibbell et al., 2000, 2001). Consistent with the above, the incorporation of CLA into neutral lipids 
was around 10-fold higher than incorporation into polar lipids in both muscle and liver in tilapia 
(Yasmin et al., 2004).  
      In mammals, CLA decreased the activity and gene expression of stearoyl coenzyme A desaturase 
(SCD) (Choi et al., 2001, 2002), and dietary CLA increased saturated fatty acids and decreased 18:1 
and monoenes in pig muscle and fat (Ramsay et al., 2001). In the present study, increased proportions 
of 18:0 and decreased 18:1n-9 were observed in flesh and, especially, liver of cod fed CLA suggesting 
inhibition of Δ9 desaturation. Increased 18:0 and decreased 18:1n-9 was previously reported in fatty 
acids of Atlantic salmon fry, and liver and flesh of smolts fed CLA suggesting that SCD activity was 
reduced (Berge et al., 2004: Kennedy et al., 2005).  Similarly, increasing levels of dietary CLA 
increased the proportions of 18:0 and decreased percentages of 18:1 in liver, muscle and viscera of 
rainbow trout juveniles (Bandarra et al., 2006), and in liver and muscle of striped bass and yellow perch 
(Twibell et al., 2000, 2001). 
       There is also evidence that CLA suppresses PUFA desaturases and elongase in cell systems 
(Chuang et al., 2001a,b; Eder et al., 2002), and CLA decreased C18 PUFA in pig muscle and fat 
(Ramsay et al., 2001), and DHA in chicken tissues (Yang et al., 2003).  Decreased tissue PUFA levels 
after feeding CLA has been reported in yellow perch and tilapia (Twibell et al., 2001; Yasmin et al., 
2004). In striped bass, CLA increased PUFA levels in liver but decreased PUFA in muscle (Twibell et 
al., 2000).  Dietary CLA increased total n-3PUFA, especially DHA, in salmon fry (Berge et al., 2004), 
but had no effect on PUFA levels in liver, and appeared to be deposited in flesh at the expense of EPA 
and DHA, in salmon smolts (Kennedy et al., 2005).   In the present study, CLA had no effect on PUFA 
levels in either liver or flesh of cod. This was perhaps not unexpected as the activity of the PUFA 
desaturation/elongation pathway is very low in cod (Bell et al., 2006).  In contrast, however, dietary 
TTA significantly increased the percentage of DHA, and decreased the proportions of EPA and total n-
6PUFA in flesh of cod.  This could be a result of increased conversion of EPA to DHA, but there is no 
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evidence from previous studies to support TTA having an effect on fatty acid desaturation or 
elongation (Berge et al., 2002).  Therefore, it may be more likely due to specificity of β-oxidation, with 
DHA being more resistant to oxidation than EPA (Tocher, 2003).   
      Although not consistently observed, some studies had suggested that CLA might enhance growth 
and feed efficiency in young rodents (Pariza et al., 2001).  Thus, a further aim of the present trial was to 
determine if dietary CLA or TTA had beneficial effects on growth parameters in Atlantic cod.   
However, neither CLA nor TTA had any effect on growth (SGR, TGC) or feed efficiency (FCR) in the 
present trial.  In recent studies on salmonids, no effects of dietary CLA on growth rates or FCR were 
observed in Atlantic salmon fry (Berge et al., 2004), or smolts (Kennedy et al., 2005), or in juvenile 
rainbow trout (Figuierdo-Silva et al., 2005) fed diets containing up to 2% CLA.  Similarly, no effects 
on weight gain or feed efficiency were noted in juvenile yellow perch or catfish fed diets containing up 
to 1% CLA (Twibell et al., 2001; Twibell and Wilson, 2003), or in juvenile tilapia fed CLA at up to 5% 
of diet (Yasmin et al., 2004).   However, growth of tilapia was inhibited by 10% CLA, as was growth 
of carp (Cyprinus carpio) and rockfish (Sebastes schlegeli) at both 5 and 10% CLA (Choi et al., 1999).  
Therefore, the data are consistent in suggesting that dietary CLA does not have any beneficial effects 
on growth performance in a variety of fish species, and can inhibit growth at high inclusion levels.  In 
contrast, in the only other study of dietary TTA in fish, growth was inhibited in salmon smolts as 
evidenced by decreased final weights, SGRs and TGCs, although FCR was unaffected (Moya-Falcon et 
al., 2004).   
 
5. Conclusion 
 
   The results of the present study only partially supported the hypotheses that were tested.  CLA and 
TTA at the levels used had few beneficial effects in Atlantic cod and did not enhance growth 
parameters, or improve feed conversion or potential yield through decreased adiposity or liver lipid 
 17 
deposition.  However, nutritional quality could be enhanced, and cod fed CLA and/or TTA could be 
beneficial in the human diet, through provision of bioactive fatty acids with no detrimental effects on n-
3 PUFA levels. 
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Legends to Figures 
 
Fig. 1. Effects of conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA) on carnitine 
palmitoyltransferase-I activities in tissue homogenates of liver, red and white muscle of cod. Results 
are presented relative to the activity in fish fed fish oil for each tissue and are means ± SD (n = 6).  
Different letters denote significant differences between dietary treatments within each tissue. CLA1 
and CLA2, fish fed 0.5% and 1% CLA, respectively; FO, fish fed fish oil alone; TTA, fish fed 0.5% 
TTA. 
 
Fig. 2. Effects of conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA) on acylCoA 
oxidase activities in tissue homogenates of liver, red and white muscle of cod. Results are presented 
relative to the activity in fish fed fish oil for each tissue and are means ± SD (n = 6). Different letters 
denote significant differences between dietary treatments within each tissue. CLA1 and CLA2, fish fed 
0.5% and 1% CLA, respectively; FO, fish fed fish oil alone; TTA, fish fed 0.5% TTA. 
 26 
 
Table 1  
Formulations (percentage of dry ingredients) and proximate
compositions (percentage of total diet) of the experimental diets
Fishmeal
Sunflower meal
Wheat gluten
Legume seeds
Micronutrients
Fish oil
CLA
TTA
Moisture 7.5 ± 0.1
ab
7.3 ± 0.3 b 8.0 ± 0.2 a 8.0 ± 0.2 a
Lipid 14.8 ± 0.3 15.4 ± 0.8 15.4 ± 0.7 15.4 ± 0.5
Protein 49.9 ± 0.4 50.2 ± 0.1 49.7 ± 0.4 49.5 ± 0.5
Ash 10.6 ± 0.0 ab 10.7 ± 0.1 a 10.5 ± 0.0 b 10.5 ± 0.0 b
Results for proximate compositions are means ± S.D. (n=3). Micronutrients, 
includes essential amino acids (methionine and lysine), vitamins and minerals, 
Biomar A/S, Brande, Denmark.
FO, control diet containing fish oil alone; CLA1 and CLA2, diets supplemented 
with 0.5 and 1% CLA; TTA, diet supplemented with 0.5% TTA. 
0 0 0
8.37.1
0
0.5
0.4
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Fatty acid compositions (percentage of weight) of experimental diets
containing conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA)
14:0 7.2 ± 0.1 a 6.8 ± 0.2 b 6.2 ± 0.1 c 6.2 ± 0.0 c
15:0 0.6 ± 0.0 0.5 ± 0.0 b 0.5 ± 0.0 b 0.5 ± 0.0 b
16:0 19.7 ± 0.2 a 18.9 ± 0.1 b 18.2 ± 0.0 c 18.7 ± 0.1 b
18:0 4.0 ± 0.0 4.0 ± 0.0 4.0 ± 0.0 3.9 ± 0.0
Total saturated1 31.8 ± 0.3 a 30.5 ± 0.3 b 29.1 ± 0.1 c 29.3 ± 0.1 c
16:1n-7 7.8 ± 0.1 a 7.4 ± 0.1 b 7.0 ± 0.2 c 7.4 ± 0.0 b
18:1n-9 9.9 ± 0.1 c 10.8 ± 0.0 b 11.8 ± 0.2 a 9.8 ± 0.1 c
18:1n-7 3.2 ± 0.0 a 3.1 ± 0.1 a 2.8 ± 0.0 b 3.1 ± 0.0 a
20:1n-9 2.3 ± 0.0 2.2 ± 0.0 2.3 ± 0.2 2.3 ± 0.0
22:1n-11 3.2 ± 0.0 a 3.1 ± 0.0 ab 3.0 ± 0.0 b 3.1 ± 0.0 a
24:1n-9 0.6 ± 0.0 0.5 ± 0.1 0.5 ± 0.0 0.5 ± 0.0
Total monoenes2 27.3 ± 0.2 a 27.4 ± 0.2 a 27.6 ± 0.1 a 26.5 ± 0.0 b
CLA (9c,11t) 0.0 ± 0.0 c 1.8 ± 0.1 b 3.2 ± 0.2 a 0.0 ± 0.0 c
CLA (10t,12c) 0.0 ± 0.0 c 1.7 ± 0.1 b 3.1 ± 0.2 a 0.0 ± 0.0 c
TTA 0.0 ± 0.0 b 0.0 ± 0.0 b 0.0 ± 0.0 b 2.8 ± 0.2 a
18:2n-6 5.7 ± 0.1 b 5.6 ± 0.0 b 5.9 ± 0.0 a 5.6 ± 0.1 b
20:4n-6 1.1 ± 0.0 a 1.0 ± 0.0 b 0.9 ± 0.0 b 1.1 ± 0.0 a
Total n-6 PUFA3 7.8 ± 0.0 a 7.6 ± 0.1 b 7.7 ± 0.1 ab 7.6 ± 0.1 b
18:3n-3 1.0 ± 0.0 a 1.0 ± 0.0 a 0.9 ± 0.0 b 1.1 ± 0.0 a
18:4n-3 2.5 ± 0.0 a 2.4 ± 0.0 b 2.2 ± 0.0 c 2.5 ± 0.0 a
20:4n-3 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.0
20:5n-3 14.0 ± 0.0 a 13.2 ± 0.2 b 12.3 ± 0.1 c 14.2 ± 0.1 a
22:5n-3 1.9 ± 0.5 1.5 ± 0.0 1.4 ± 0.0 1.7 ± 0.0
22:6n-3 12.8 ± 0.0 b 12.3 ± 0.1 c 11.9 ± 0.1 d 13.4 ± 0.1 a
Total n-3 PUFA4 33.1 ± 0.5 b 31.1 ± 0.3 c 29.3 ± 0.2 d 33.9 ± 0.2 a
Total PUFA 40.9 ± 0.4 a 38.7 ± 0.3 b 37.0 ± 0.3 c 41.5 ± 0.3 a
n-3/n-6 4.2 ± 0.1 b 4.1 ± 0.0 b 3.8 ± 0.0 c 4.5 ± 0.0 a
Values are means ± SD (n = 3). Superscript letters denote significant differences 
between diets as determined by ANOVA as described in the Materials and Methods.
1, includes 20:0, present in some samples at up to 0.3%; 
2, includes 120:1n-7 present in some samples at up to 0.3%;
3, includes 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 present at up 0.4%;
4, includes 20:3n-3 present at up to 0.1%; PUFA, polyunsaturated fatty acids. 
Table 2  
FO CLA1 CLA2 TTA
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Table 3
Growth and biometric parameters  for Atlantic cod (Gadus morhua) fed diets containing
conjugated linoleic acid (CLA) and tetradecylthioacetic acid (TTA) for three months
Initial weight (g)1 125 ± 14 b 130 ± 15 a 125 ± 15 b 127 ± 15 ab
Final weight (g)1 307 ± 50 305 ± 47 309 ± 57 303 ± 44
FCR2 0.80 ± 0.01 b 0.84 ± 0.02 a 0.80 ± 0.02 b 0.83 ± 0.00 ab
SGR2 1.03 ± 0.04 0.98 ± 0.05 1.04 ± 0.02 1.00 ± 0.02
TGC2 1.93 ± 0.08 1.84 ± 0.10 1.95 ± 0.04 1.87 ± 0.04
Gutted weight (%)3 81.5 ± 0.2 c 81.7 ± 0.3 bc 82.2 ± 0.4 a 81.8 ± 0.2 b
Condition factor (K)3 1.14 ± 0.04 a 1.12 ± 0.01 b 1.14 ± 0.03 a 1.12 ± 0.01 b
HSI3 11.0 ± 0.5 b 11.3 ± 0.1 a 10.9 ± 0.3 b 10.6 ± 0.1 c
VSI3 9.3 ± 1.2 a 8.0 ± 0.7 b 8.9 ± 0.2 a 8.8 ± 0.2 a
Mortality (n)
Data are presented as means ± SD, 1n = 146-150,  2n = 3,  3n = 27; 
Condition factor (K) = (wet weight in g) x 100)/(length in mm3) x 1000;
FCR, feed conversion ratio = feed consumed (kg )/ weight gain (kg); 
TGC, thermal growth coefficient = 100 x (final weight1/3 - initial weight1/3) / sum day-degrees;
HSI, Hepato-somatic index =100 x liver weight x body weight -1; 
SGR, specific growth rate (%/day) = 100 x [(Final Weight / Initial Weight)/Days -1]; 
VSI, Viscero-somatic index = 100 x viscera weight x body weight -1;  
Superscript letters denote significant effects of dietary treatment as determined by ANOVA 
as described in the Materials and Methods.
1 2 1 4
FO CLA1 CLA2 TTA
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Table  4 
Proximate composition of whole Atlantic cod (Gadus morhua)
Diet
Moisture 73.6 ± 0.6 73.3 ± 0.6 73.8 ± 0.6 73.9 ± 0.7
Protein 60.4 ± 1.4 59.7 ± 1.7 59.1 ± 1.7 60.6 ± 1.4
Lipid 26.2 ± 1.9 28.4 ± 2.2 27.9 ± 2.1 26.7 ± 1.8
Ash 9.6 ± 0.7 9.3 ± 0.5 9.5 ± 0.6 9.9 ± 0.4
Values are means ± SD of 9 fish. There were no significant differences
between dietary treatment as determined one-way ANOVA .
CLA, conjugated linoleic acid; TTA, tetrathioacetic acid.
FO CLA1 CLA2 TTA
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Table 5
Lipid content (percentage of wet weight) and class composition (percentage of
total lipid) of liver and flesh  of Atlantic cod (Gadus morhua) fed conjugated 
linoleic acid (CLA) and tetradecylthioacetic acid (TTA)
Lipid class
Liver
Lipid content 53.8 ± 2.6 ab 50.0 ± 2.1 b 55.2 ± 2.0 a 55.2 ± 2.0 a
PC 1.5 ± 0.2 b 1.8 ± 0.1 ab 2.0 ± 0.4 a 1.5 ± 0.1 b
PE 1.3 ± 0.1 b 1.3 ± 0.2 b 1.7 ± 0.3 a 0.9 ± 0.3 c
Total polar 2.8 ± 0.3 b 3.1 ± 0.3 ab 3.7 ± 0.7 a 2.4 ± 0.3 b
Total neutral 97.2 ± 0.3 a 96.9 ± 0.3 ab 96.3 ± 0.7 b 97.6 ± 0.3 a
Cholesterol 4.4 ± 0.6 ab 4.9 ± 1.4 ab 5.4 ± 0.3 a 3.9 ± 0.6 b
Triacylglycerol 92.7 ± 0.8 a 92.0 ± 1.6 ab 90.9 ± 0.8 b 93.6 ± 0.8 a
Free fatty acid
Steryl ester
Flesh
Lipid content 0.8 ± 0.0 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.0
PC 30.7 ± 1.8 a 27.9 ± 1.6 b 30.8 ± 1.5 a 28.7 ± 1.2 ab
PE 17.9 ± 1.2 a 15.6 ± 0.7 b 17.1 ± 0.6 a 17.6 ± 0.5 a
PS 2.5 ± 0.6 2.8 ± 0.4 2.7 ± 0.4 3.2 ± 0.5
PI 3.8 ± 0.6 4.1 ± 0.6 3.8 ± 0.7 4.3 ± 0.5
PG/CL 2.9 ± 0.7 b 2.8 ± 0.3 b 2.8 ± 0.4 b 3.7 ± 0.2 a
Sphingomyelin 1.5 ± 0.4 1.7 ± 0.3 1.6 ± 0.2 1.6 ± 0.6
Lyso-PC 1.8 ± 0.3 bc 2.2 ± 0.2 a 2.0 ± 0.2 ab 1.5 ± 0.2 c
Total polar 61.2 ± 2.1 a 57.2 ± 1.6 b 60.8 ± 1.2 a 60.5 ± 2.1 a
Total neutral 38.8 ± 2.1 b 42.8 ± 1.6 a 39.2 ± 1.3 b 39.5 ± 2.1 b
Cholesterol 16.1 ± 0.9 15.6 ± 0.3 15.2 ± 1.8 15.7 ± 0.4
Triacylglycerol 6.9 ± 1.2 b 6.3 ± 1.6 b 5.7 ± 1.1 b 9.2 ± 0.8 a
Free fatty acid 11.9 ± 1.2 b 15.1 ± 1.6 a 13.0 ± 1.7 ab 11.5 ± 1.4 b
Steryl ester 3.9 ± 0.4 b 5.9 ± 0.9 a 5.4 ± 0.4 a 3.2 ± 0.6 b
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.  
tr tr tr tr
PC, phosphatidylcholine; PE, phosphatidylethanolamine; PG, phosphatidylglycerol; 
PI, phosphatidylinositol; PS, phosphatidylserine; trace, < 0.5%. 
tr tr tr tr
Superscript letters denote significant differences between dietary treatments as  
determined by ANOVA  as described in the Materials and Methods. CL, cardiolipin; 
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Fatty acid composition (percentage of weight) of total lipid from liver of
Atlantic cod (Gadus morhua) fed conjugated linoleic acid (CLA) and 
tetradecylthioacetic acid (TTA)
14:0 2.9 ± 0.3 b 3.4 ± 0.1 a 3.3 ± 0.2 a 2.8 ± 0.1 b
16:0 15.7 ± 0.5 a 15.6 ± 0.2 a 15.0 ± 0.7 ab 14.7 ± 0.6 b
18:0 5.6 ± 0.2 b 8.3 ± 0.5 a 8.7 ± 0.4 a 4.9 ± 0.2 c
Total saturated1 24.5 ± 0.7 b 27.7 ± 0.6 a 27.3 ± 1.0 22.6 ± 0.9 c
16:1n-7 6.6 ± 0.2 a 6.2 ± 0.1 b 5.9 ± 0.2 c 6.7 ± 0.2 a
18:1n-9 18.8 ± 0.6 a 15.7 ± 0.3 b 15.6 ± 0.3 b 19.6 ± 0.7 a
18:1n-7 5.3 ± 0.2 a 4.8 ± 0.2 b 4.8 ± 0.1 b 5.7 ± 0.4 a
20:1n-9 5.2 ± 0.1 5.1 ± 0.2 5.1 ± 0.3 5.1 ± 0.2
22:1n-11 3.3 ± 0.2 a 3.2 ± 0.1 ab 2.9 ± 0.3 b 3.3 ± 0.3 a
24:1n-9 0.3 ± 0.1 0.3 ± 0.0 0.3 ± 0.0 0.4 ± 0.1
Total monoenes2 40.0 ± 1.1 a 35.6 ± 0.6 b 34.9 ± 0.5 b 41.0 ± 1.1 a
CLA (9c,11t) 0.0 ± 0.0 c 0.9 ± 0.2 b 1.6 ± 0.5 a 0.0 ± 0.0 c
CLA (10t,12c) 0.0 ± 0.0 c 0.6 ± 0.1 b 1.3 ± 0.4 a 0.0 ± 0.0 c
TTA 0.0 ± 0.0 b 0.0 ± 0.0 b 0.0 ± 0.0 b 0.6 ± 0.1 a
18:2n-6 5.4 ± 0.1 5.5 ± 0.1 5.5 ± 0.0 5.5 ± 0.2
20:4n-6 0.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0 0.8 ± 0.0
Total n-6 PUFA3 7.2 ± 0.2 7.2 ± 0.1 7.2 ± 0.0 7.0 ± 0.3
18:3n-3 1.0 ± 0.0 0.9 ± 0.0 0.9 ± 0.0 1.0 ± 0.0
18:4n-3 2.0 ± 0.1 2.0 ± 0.1 1.9 ± 0.0 2.0 ± 0.1
20:4n-3 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.0
20:5n-3 11.5 ± 0.6 11.2 ± 0.2 11.2 ± 0.3 11.7 ± 0.5
22:5n-3 1.5 ± 0.1 1.5 ± 0.0 1.5 ± 0.0 1.5 ± 0.1
22:6n-3 11.5 ± 0.8 11.6 ± 0.3 11.5 ± 0.4 11.8 ± 0.7
Total n-3 PUFA4 28.3 ± 1.6 28.0 ± 0.6 27.6 ± 0.8 28.8 ± 1.4
Total PUFA 35.5 ± 1.7 35.2 ± 0.6 34.8 ± 0.8 35.9 ± 1.6
n-3/n-6 3.9 ± 0.2 3.9 ± 0.1 3.8 ± 0.1 4.1 ± 0.1
1, includes 15:0, present in some samples at up to 0.3%; 
2, includes 20:1n-7 present in some samples at up to 0.3%;
3, includes 18:3n-6, 20:2n-6, 20:3n-6, 22:4n-6 and 22:5n-6 present at up 0.3%;
4, includes 20:3n-3 present at up to 0.1%; PUFA, polyunsaturated fatty acids. 
Values are means ± SD of 6 samples each of tissue pooled from 3 fish. 
Superscript letters denote significant differences between dietary treatments as 
determined by ANOVA  as described in the Materials and Methods. 
Table 6
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Fatty acid composition (percentage of weight) of total lipid from flesh of
Atlantic cod (Gadus morhua) fed conjugated linoleic acid (CLA) and 
tetradecylthioacetic acid (TTA)
14:0 1.6 ± 0.2 a 1.3 ± 0.1 b 1.3 ± 0.1 b 1.0 ± 0.0 c
16:0 19.3 ± 0.8 ab 19.2 ± 0.8 ab 18.6 ± 0.5 b 20.1 ± 0.4 a
18:0 3.2 ± 0.1 b 4.0 ± 0.1 a 3.9 ± 0.2 a 3.4 ± 0.1 b
Total saturated1 24.4 ± 0.9 24.8 ± 0.8 24.2 ± 0.3 24.8 ± 0.5
16:1n-7 2.9 ± 0.3 a 2.6 ± 0.1 ab 2.4 ± 0.2 b 2.3 ± 0.2 b
18:1n-9 9.2 ± 0.1 a 8.8 ± 0.2 ab 8.5 ± 0.5 b 8.7 ± 0.4 ab
18:1n-7 2.9 ± 0.0 a 2.8 ± 0.1 ab 2.7 ± 0.1 b 2.7 ± 0.1 b
20:1n-9 1.0 ± 0.1 1.1 ± 0.2 1.0 ± 0.1 1.0 ± 0.2
22:1n-11 0.3 ± 0.0 0.3 ± 0.1 0.3 ± 0.0 0.3 ± 0.0
24:1n-9 0.3 ± 0.0 0.3 ± 0.0 0.3 ± 0.1 0.4 ± 0.1
Total monoenes2 16.7 ± 0.4 a 15.9 ± 0.3 ab 15.2 ± 0.8 b 15.4 ± 0.6 b
CLA (9c,11t) 0.0 ± 0.0 c 0.3 ± 0.1 b 0.7 ± 0.0 a 0.0 ± 0.0 c
CLA (10t,12c) 0.0 ± 0.0 c 0.5 ± 0.1 b 1.2 ± 0.1 a 0.0 ± 0.0 c
TTA 0.0 ± 0.0 b 0.0 ± 0.0 b 0.0 ± 0.0 b 1.6 ± 0.3 a
18:2n-6 4.1 ± 0.1 4.0 ± 0.4 4.1 ± 0.3 3.9 ± 0.1
20:4n-6 1.9 ± 0.0 a 1.9 ± 0.1 a 1.9 ± 0.0 a 1.8 ± 0.0 b
22:5n-6 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0 0.6 ± 0.0
Total n-6 PUFA3 7.1 ± 0.2 a 7.2 ± 0.3 a 7.0 ± 0.2 a 6.5 ± 0.1 b
18:3n-3 0.6 ± 0.0 a 0.6 ± 0.1 a 0.6 ± 0.0 a 0.5 ± 0.0 b
18:4n-3 0.9 ± 0.0 a 0.8 ± 0.1 ab 0.8 ± 0.1 ab 0.7 ± 0.0 b
20:4n-3 0.7 ± 0.0 0.7 ± 0.0 0.6 ± 0.0 0.7 ± 0.0
20:5n-3 18.6 ± 0.3 a 18.0 ± 0.9 a 18.2 ± 0.5 a 16.4 ± 0.2 b
22:5n-3 2.2 ± 0.0 a 2.2 ± 0.1 a 2.2 ± 0.0 a 2.1 ± 0.0 b
22:6n-3 28.6 ± 0.6 b 28.9 ± 0.8 b 29.4 ± 1.3 b 31.0 ± 0.7 a
Total n-3 PUFA4 51.7 ± 0.9 51.3 ± 0.5 51.7 ± 0.7 51.4 ± 0.8
Total PUFA 58.9 ± 0.9 58.5 ± 0.8 58.7 ± 0.5 58.3 ± 0.6
n-3/n-6 7.2 ± 0.2 b 7.1 ± 0.2 b 7.4 ± 0.3 b 7.8 ± 0.2 a
1, includes 15:0 and 20:0, present in some samples at up to 0.3%; 
2, includes 16:1n-9 and 20:1n-11 present in some samples at up to 0.1%;
3, includes 18:3n-6, 20:2n-6, 20:3n-6 and 22:4n-6 present in some samples at up 0.3%;
4, includes 20:3n-3 present at up to 0.1%; PUFA, polyunsaturated fatty acids. 
Values are means ± SD of 6 samples each of tissue pooled from 3 fish.
Superscript letters denote significant differences between dietary treatments as
determined by ANOVA  as described in the Materials and Methods.
Table 7 
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